SURG eps in a glimpse
Analyst Rating Consensus
1
Ratings
SURG Price Target
Highest Price Target
$8.50
459.21% Upside
)Mean Price Target
$8.50
459.21% Upside
)Lowest Price Target
$8.50
459.21% Upside
)SURG Recent Analyst Ratings
Actual EPS vs Estimated EPS
How EPS can be helpful
Understanding the true essence of Earnings Per Share (EPS) for a company can be a complex endeavor. EPS, essentially a measure of a company's profitability on a per-share basis, is often used by investors as a barometer of financial health. However, it's crucial to recognize that EPS can be subject to manipulation through various accounting techniques and management strategies.
SURG Earnings History
Frequently Asked Questions
Brokerage firms have given SURG stock an average recommendation of Buy. 1 analysts have given their ratings to SURG out of which 0 analysts have given strong buy call, 1 analysts have given buy call, 0 analysts rate it hold, 0 analysts advocate strong sell call, and 0 analysts has given sell rating. The average target price of $8.50 gives the stock implied upside of roughly 459.21% over the next year or so.
Analysts suggest SURG's stock price would rise to a high of $8.50.
Within the next 12 months, analysts predict the SURG stock price could move to $8.50.
SURG stock has an average analyst estimate of $8.50.
SURG shares are currently trading 459.21% above this price target.
Its quarterly earnings per share (EPS) came in at -$0.66 versus consensus estimates of -$0.17, and below the comparable year-ago quarter’s EPS of $0.40.
SURG's forecasts by analysts estimating quarterly EPS at -$0.25 and $20.50 for the whole year.
The analysts have projected 15% EPS growth for SURG in the next five years, compared to growth rates of N/A in the past five years.